User profiles for "author:Bożena Cybulska-Stopa"

Bożena Cybulska-Stopa

Narodowy Instytut Onkologii (NIO)
Verified email at vp.pl
Cited by 479

Principles of prophylactic and therapeutic management of skin toxicity during treatment with checkpoint inhibitors

G Kamińska-Winciorek, B Cybulska-Stopa… - … in Dermatology and …, 2019 - termedia.pl
The introduction of immunotherapy into the treatment of cancer patients has revolutionised
the oncological approach and significantly improved patient survival. The key drugs are …

A practical approach to the 2022 ESC cardio-oncology guidelines: Comments by a team of experts–cardiologists and oncologists

P Leszek, A Klotzka, S Bartuś… - Polish Heart …, 2023 - journals.viamedica.pl
The 2022 European Society of Cardiology (ESC) guidelines [1] are a comprehensive
document, prepared jointly by experts in cardiology and oncology. In the case of oncology …

[HTML][HTML] Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective …

P Rutkowski, A Indini, M De Luca, B Merelli… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Obesity is a risk factor for malignancy; however, its prognostic role in patients
with metastatic melanoma is controversial. We aim to investigate the prognostic role of body …

Cutaneous melanoma

P Rutkowski, PJ Wysocki… - Oncology in clinical …, 2020 - journals.viamedica.pl
According to the authors and editors, this report contains the most justified principles of
diagnostic and therapeutic procedures prepared considering the scientific value of evidence …

Expert recommendations on diagnostic-therapeutic management of melanoma patients

P Rutkowski, PJ Wysocki, K Kozak… - Oncology in Clinical …, 2022 - journals.viamedica.pl
According to the authors and editors, this report contains the best justified principles of
diagnostic and therapeutic procedures prepared on the basis of the scientific value of …

Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma: a multicentre study

B Cybulska-Stopa, I Ługowska… - … in Dermatology and …, 2019 - termedia.pl
Immune checkpoint inhibitors therapy in older patients (≥ 70 years) with metastatic melanoma:
a multicentre study Page 1 Advances in Dermatology and Allergology 5, October / 2019 566 This …

[HTML][HTML] Multimodal treatment of advanced mucosal melanoma in the era of modern immunotherapy

P Teterycz, AM Czarnecka, A Indini, MJ Spałek… - Cancers, 2020 - mdpi.com
Simple Summary Immunotherapy revolutionized the treatment of cutaneous melanoma and
greatly improved treatment outcomes in this group of patients. Mucosal melanoma is a rare …

Efficacy of ipilimumab after anti-PD-1 therapy in sequential treatment of metastatic melanoma patients-Real world evidence

B Cybulska-Stopa, P Rogala, AM Czarnecka… - Advances in Medical …, 2020 - Elsevier
Purpose Immunotherapy has become a standard treatment option for patients with
metastatic melanoma, and the use of checkpoint inhibitors significantly improves the …

Long-term clinical evidence of comparable efficacy and toxicity of nivolumab and pembrolizumab in advanced melanoma treatment

B Cybulska-Stopa, K Piejko, K Ostaszewski… - Melanoma …, 2023 - journals.lww.com
Pembrolizumab and nivolumab (anty-PD-1 antibody) are commonly used for the treatment of
melanoma patients. However, their efficacy and safety have never been directly compared …

[HTML][HTML] Modern Approach to Melanoma Adjuvant Treatment with Anti-PD1 Immune Check Point Inhibitors or BRAF/MEK Targeted Therapy: Multicenter Real-World …

J Placzke, M Rosińska, P Sobczuk, M Ziętek… - Cancers, 2023 - mdpi.com
Simple Summary Performing this real-world analysis, we intended to see if postoperative
(adjuvant) systemic treatment outcomes in a Polish melanoma patient population are …